Search

everythinglearnresearchcommunity

for

Search:↓

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

Mogamulizumab can cause hair loss and skin rashes.

Niosomes are a promising, stable, and cost-effective drug delivery system with potential for improved targeting and safety.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.

Some medications might reverse gray hair, especially those that reduce inflammation or stimulate pigment production, and vitamin B might help.

Ethosomes improve drug delivery through the skin but may have side effects like irritation.

The hepatitis B vaccine did not cause hair loss in the tested mice.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

A man lost all his hair permanently after hepatitis C treatment, a side effect not seen before.

Finding new uses for existing drugs is promising and can lead to safer, more effective medicines.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

Drug metabolism affects how long a drug works, its interactions, activation, and toxicity, and is influenced by genetics, diet, illness, and other drugs.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

No cure exists for alopecia areata, and treatments are personalized.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

A man lost all his hair after stopping hepatitis C treatment and it didn't grow back.

Ethosomes are a promising way to deliver drugs through the skin.

Ayurvedic herbs may reduce side effects and improve effectiveness of cancer treatments.

Microneedles improve drug delivery in various body parts, are safe and painless, and show promise in cosmetology, vaccination, insulin delivery, and other medical applications.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Most patients treated with low-dose alpha-interferon for malignant melanoma experienced skin side effects, with hair loss being the most frequent.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

A woman developed white patches on her skin and curly hair after hepatitis C treatment, likely due to the medication interferon alpha.

Sodium Valproate nanospanlastics could be a safe and effective treatment for Androgenic Alopecia, with fewer side effects than minoxidil.